M any studies have assessed the factors related to prognosis after acute myocardial infarction (MI).1 However, although it is increasingly well recognized that the prognosis of men and women with heart diseases of various types may differ,2 evaluations of the post-MI prognosis of women have been hampered by relatively small numbers of women (less than 600 in every report to date) or by possible patient-selection biases. Some reviews assert that the outlook for women after MI is less favorable than it is for men,3 yet a host of articles in the literature actually found an equivalent, or even better, prognosis in women, in both short-term4-7and longer-term8-12 studies. Demographic and medical data during hospitalization and from 1-year follow-up were collected for all registered MI patients, providing an opportunity to evaluate the influence of various factors on the short-term (in-hospital) and long-term (1-year) prognosis in the course of acute MI.
In-Hospital and 1-Year Mortality in 1, 524 Women After Myocardial Infarction M any studies have assessed the factors related to prognosis after acute myocardial infarction (MI).1 However, although it is increasingly well recognized that the prognosis of men and women with heart diseases of various types may differ,2 evaluations of the post-MI prognosis of women have been hampered by relatively small numbers of women (less than 600 in every report to date) or by possible patient-selection biases. Some reviews assert that the outlook for women after MI is less favorable than it is for men,3 yet a host of articles in the literature actually found an equivalent, or even better, prognosis in women, in both short-term4-7and longer-term8-12 studies. and prognostic factors from a series of 1,524 women in the Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT) Registry.
Methods
Patients with acute MI were enrolled from 14 hospitals throughout Israel and followed for at least 1 year after MI. From November 1981 to August 1983, 5,839 consecutive MI patients were hospitalized in 14 of 21 existing coronary care units in Israel. Somewhat more than one third of the patients (n=2,276) were included in SPRINT; the results of this trial did not indicate beneficial effects of nifedipine for secondary prevention after acute MI. 13 Demographic and medical data during hospitalization and from 1-year follow-up were collected for all registered MI patients, providing an opportunity to evaluate the influence of various factors on the short-term (in-hospital) and long-term (1-year) prognosis in the course of acute MI.
The diagnosis of acute MI was established on the basis of the presence of one of three sets of condi-tions: 1) typical symptoms lasting at least 30 minutes, elevated serum levels of cardiac enzymes (creatinine kinase, aspartate aminotransferase, and lactate dehydrogenase), and electrocardiographic (ECG) findings of Q/QS with major ST and/or T wave abnormalities, dynamic ST depression or elevation, or dynamic T wave changes on comparison of two recent ECGs, 2) atypical symptoms, elevated serum levels of cardiac enzymes, and one of the following Q/QS changes on comparison of two recent ECGs: the appearance of Q/QS findings on the second ECG that were not present on the first or the appearance of major Q/QS findings that were previously only minor, and 3) typical symptoms plus ECG findings required under condition 2, without enzyme elevations.13
Data for all patients were accumulated and analyzed in the Coordinating Center of SPRINT located in the Heart Institute of the Sheba Medical Center in Tel Hashomer, Israel.
Data Acquisition
Demographic, historical, and medical variables were collected from each patient on special study forms during hospitalization and 1 year after discharge. Historical characteristics were based on self reports from patients at the time of hospitalization. All deaths were reviewed independently by two cardiologists for the assessment of mode of death, which was categorized into three main groups: 1) sudden cardiac death, 2) nonsudden cardiac death, and 3) noncardiac death.
The Minnesota Code was used for localization of acute MI of anterior (V1-V5), inferior (L-2, L-3, and aVF), lateral (L-1, aVL, and V6), and undetermined sites. 13 
Statistical Analysis
Age-adjusted death rates were compared by the Mantel-Haenszel test, which pools mortality rates over the following age groups: 49 years or less, 50-59 years, 60-69 years, and 70 years or more. Covariate adjusted odds ratios, associated with female gender, were estimated using logistic regression; the calculation was obtained by the Statistical Analysis System procedure CATMOD.14 Confidence intervals of 95% were approximated for the odds ratios by taking the antilogs of the logistic coefficients+ 1.96SE. Separate logistic regression analyses were also performed for certain subgroups, as noted in "Results" below.
Results

Description of the Population
As is characteristic of the Israeli population at large, the patients in the study came Syria); 9.8% were from Central European countries including Germany, Austria, and Hungary; 7.9% were from North African countries; and the remaining 5.3% were from various other countries of origin. The overwhelming majority were Jewish, and the racial constituency was all white. Of those patients not born in Israel, about 55% conform to the wide definition of "Ashkenazi"; the others represent "Sephardic," Oriental, and Yemenite origins.
Historical Characteristics Before Myocardial Infarction Table 1 summarizes the preinfarction characteristics of the 1,524 women compared with 4,315 men in SPRINT. The prevalence of the characteristics is age adjusted to account for the higher mean age of women (67 years for women versus 61 years for men). Even after age adjustment, important baseline characteristics differed significantly between women and men. Men were more likely to have been cigarette smokers and, notably, although 6 years younger on average, more likely to have had a previous MI; women were more likely to have been hypertensive or diabetic. Clinical Features During Myocardial Infarction Table 2 indicates age-adjusted incidence of clinical features and hospital course in the 5,839 patients by gender. There were fewer women with markedly elevated cardiac enzymes (creatine kinase and aspartate aminotransferase more than four times the upper limit of normal); however, congestive heart failure, cardiogenic shock, and cardiac arrest were each more prevalent in women. Prescriptions for digitalis and diuretic use upon discharge were equal in men and women. Short-term and 1-Year Mortality After Myocardial Infarction Table 3 indicates in-hospital mortality, 1-year mortality in patients surviving hospitalization, and cumulative 1-year mortality in the 1,524 women and 4,315 men, by age group. In every age group examined, the short-term and 1-year mortality rates were higher in women than in men. Overall, the age-adjusted inhospital risk of death in women was 1.47 times that in men; the corresponding risk ratio of postdischarge mortality was 1.27. When run under a logistic regression model with only gender and age in the model, the age-adjusted relative odds of hospital mortality associated with female gender were 1.56 (95% confidence interval, 1.34-1.84). In addition, age-adjusted rates were significantly different for women versus men for 1-year mortality in patients surviving hospitalization, and cumulative 1-year mortality.
Because of the diversity of ethnic backgrounds represented in this MI population, we also deter- MI, myocardial infarction.
For 1-year mortality in patients surviving hospitalization, risk ratios were more highly variable, probably in part due to small numbers of deaths after hospital discharge in several of the ethnic/gender groups. For example, only 10 deaths occurred in the Israeli-born women who survived hospitalization. In the two largest groups, Eastern European-born and Balkan States-born, odds ratios were 1.03 and 1.24, respectively. However, even in these groups, only 49 females and 32 females, respectively, died, so confidence intervals around these estimated odds ratios are inevitably wide. Causes of Death Table 4 lists causes of death during hospitalization and during the first year after MI, for women and men. The distributions of causes of death, both during hospitalization and after 1 year, were similar in men and women. Thus, there was no evidence that the differences in mortality were due to an increase in any particular mode of death.
Multivariate Analysis
To assess the independent association between gender and outcome, a multiple logistic function adjusting for age as well as for other indicators of mortality was calculated in the overall sample of 5,839 men and women with MI. For in-hospital mortality, after adjustment for age, congestive heart failure, history of prior MI, prolonged hypotension, lactate dehydrogenase level more than four times the upper limit of normal, Swan-Ganz catheter use, second-or third-degree atrioventricular block, and anterior MI location by ECG, gender persisted as an independent predictor of mortality, with adjusted relative odds of death in women versus men of 1 Table 6 . Once again, diabetes emerged as a factor associated with increased mortality in women, but not in men. Other factors importantly predictive of 1-year mortality in women were-along with agecongestive heart failure, history of a previous MI, and the need for digitalis as assessed on discharge. Because of the finding that diabetes may contribute importantly to the poorer prognosis in women compared with men, separate logistic function analyses were also performed in the nondiabetics in the study group. In the 4,637 nondiabetics, after covariate adjustment for age, congestive heart failure, prior MI, and the other major covariates listed in Table 5 , female gender remained a significant predictor of worse in-hospital outcome though the As found in some earlier studies,4"15-'9 but not in others,5-1" the results of this investigation showed that women suffering an acute MI fared significantly worse than men, both during hospitalization and 1 year after hospitalization. Although some earlier studies8"1',20'21 have suggested simply that the greater age of women at the time of MI accounts entirely for the differences seen in mortality between men and women, the comparison of covariate-adjusted and age-adjusted results in this study indicate that advanced age alone does not explain the higher mortality rates of women with MI observed here. After covariate adjustment for age, congestive heart failure or pulmonary congestion, higher serum enzyme levels, atrioventricular block, and previous MI, the relative odds of dying during hospitalization or within 1 year after discharge remained significantly greater in women than in men.
Previous Studies
Why have the various studies comparing outcome after MI in women and men produced inconsistent results? It may be useful to examine a small number of these reports in greater detail in an effort to account for the differences in their results or conclusions. For example, Tofier et al15 evaluated data from the Multicenter Investigation of the Limitation of Infarct Size (MILIS) based on findings after MI in 226 women and 590 men. MILIS involved five large university medical centers in the United States and used inclusion/exclusion criteria similar to those in our study. 15 Women with MI were, on average, 4 years older than men with MI (60 years versus 56 years). Crude in-hospital death rates for men and women were significantly different (13% for women and 7% for men). Similarly, in patients surviving hospitalization, the crude 48-month mortality based on life table analysis was significantly worse in women (27%) than in men (15%), and crude 48-month cumulative mortality was similarly worse in women (36%) than in men (21%). As in our data, several clinically important baseline and clinical characteristics were more prevalent in women than in men: higher mean age in women, prior hypertension (63% for women versus 50% for men), diabetes (28% for women versus 15% for men), and clinical congestive heart failure preceding the MI (12% for women versus 7% for men). To adjust for these and other differences, the MILIS investigators used an adjusted Cox proportional hazards regression model. Even after covariate adjustment, women had worse shortterm and 48-month mortality rates than did men. Thus, overall, the MILIS results closely resembled those reported here, and the conclusions of the authors were similar to ours in the SPRINT data. Importantly, the MILIS study also suggested that the excess female mortality was seen primarily in blacks.
Dittrich et a18 reported results from a multicenter study of 538 women and 1,551 men with MI; four major medical centers in San Diego and Vancouver, BC, were involved in the study. Crude hospital death rate was higher in women than in men (17.5% versus 12.3%), and 1-year mortality in those who survived hospitalization was also higher in women (13% versus 11%), similar to our findings. However, in contrast to our study and that of Tofler et al,15 after statistical adjustment for baseline differences using stepwise linear discriminant analysis, no significant differences between short-term or 1-year outcome in women compared with men remained. Dittrich et al8 concluded that, despite differences in certain clinical features of MI in women versus men, the increased mortality observed in women after MI was "due to their greater age."
As in our study and that of Tofler et al'5 (MILIS), Dittrich et a18 found that women with MI were older than men (69 versus 62 years) and that women were more likely to have had a history of congestive heart failure (12% for women versus 7% for men). However, systemic hypertension was not significantly more prevalent in women than in men, nor was diabetes mellitus. It is possible, therefore, that case mix (e.g., fewer diabetic women) could have strongly influenced the results obtained, leading to different conclusions by the authors in our study and that of Tofler et al compared with studies such as that of Dittrich et al. In addition, possibly due to the smaller number of MI cases, mortality differences of a magnitude similar to those we observed were found to be not statistically significant in the study of Dittrich et al.
Case Mix and Outcome
It is possible that other factors in case mix may account for some, if not a majority, of the differences in results between studies. For example, as noted by Tofler et al, 15 in the MILIS study, a high proportion of blacks were included, and their mortality was significantly higher than that observed in whites. Similarly, in the present study, some of the excess mortality in women undoubtedly was due to the higher prevalence of diabetes in women compared with that in men. Several previous reports22-25 have shown a similarly poor prognosis after MI in diabetics, especially in women. However, even when diabetics were excluded from the logistic regression analysis, female gender remained a significant independent predictor of hospital mortality in our study (odds ratio, 1.40; 95% confidence interval, 1.14-1.72). The 1-year mortality differential between men and women narrowed substantially, however, in hospital survivors, especially when the analysis was restricted only to nondiabetics. This point is worth emphasizing, since the mortality differential observed here between men and women was most prominent during the hospital phase of MI.
Long-term follow-up from the Framingham study12 has shown that the impact of risk factors, such as diabetes in women, may have a particularly deleterious effect after MI. Wong et al12 found that, after statistical adjustment for a higher post-MI prevalence of systolic hypertension, elevated serum cholesterol, age, and diabetes, females in the Framingham study actually had a long-term (20-30 years) survival advantage over men after MI. It is possible that the standard cardiac risk factors are not only more prevalent in women who develop MI but may interact with the coronary artery pathobiology or myocardial metabolism in an especially deleterious fashion to account for the poorer in-hospital and long-term prognosis of women. Thus, although women fared particularly poorly after MI in our study, especially during hospitalization, diabetic women fared especially poorly. Racial, Ethnic, and Cultural Considerations In addition to racial or coronary risk factor differences between populations, ethnic differences could account for discrepant results between this study and prior reports of MI outcome in women. Israel, like the United States, is ethnically heterogeneous. In Israel, the majority of residents are foreign-born, having emigrated from a large number of countries. Two thirds of the patients in our study originated from Europe. Although differences in ethnic origin could account, in part, for some of our findings, the data are not strongly supportive of this idea. As noted, the female mortality excess during the hospital phase of MI was observed in every major ethnic group included in our study. In contrast to the ethnic heterogeneity, there was no racial heterogeneity in the study population. Therefore, we also cannot account for our findings based on racial differences between groups of MI patients.
It is conceivable that other factors that distinguish the Israeli population could contribute to the results we observed. In prior reports, it has been noted that the Israeli male/female ischemic heart disease mortality is lower overall than that found in many western countries such as the United States. 26 This difference between countries in mortality ratios cannot be accounted for by differences in prevalence of major coronary risk factors such as hypertension, hyperlipidemia, cigarette smoking, or diabetes.26 Risk factor surveys from Israel show the prevalence of major risk factors to be similar to those observed in the United States, and similar male/female differences in risk factors have also been observed in the two countries.26-29 There may be cultural differences in the female role model in Israel that contribute to poorer outcome after MI. These might include delay in reporting MI symptoms, delay in receiving MI care, or earlier discharge from hospital to return to home duties. These possible cultural differences have not been explored and may warrant further consideration. Unknown biological factors could also be contributing to the mortality differences reported here.
Clinical Implications
There are important clinical implications of our findings. First, our data indicate that women who develop MI, as suggested by some but not all of the earlier literature, are truly at greater risk of mortality from MI and, therefore, in general, deserve aggressive in-hospital and posthospital assessment and treatment. The especially increased in-hospital mortality may justify special efforts to improve early recognition and treatment of MI in women, including prompt thrombolysis. The composite literature including this study implies, further, that women with risk factors, especially diabetes, form an especially high-risk subset warranting even more intensive post-MI attention and treatment. These data also indicate the critical need for thorough study of the pathogenesis of the poor outcome of women after MI, possibly focusing on the role of diabetes and its associated increased platelet aggregability, hormonal differences between men and women, and sociocultural factors that distinguish the female role from that of men in various societies. Appendix SPRINT Study Group Henry N. Neufeld, MD (deceased); Jacob Agmon, MD; Solomon Behar, MD; Uri Goldbourt, PhD;
